Novavax Global Commercial Operations and COVID-19 Vaccine Update

Robust efficacy in adolescents novavax All strains NVX-COV2373 (N = 1,205) Placebo (N = 594) Cases Mild Moderate Severe Vaccine Efficacy: Overall 5 (<1%) 6 0 0 14 (2%) 14 0 80% (95% CI: 47, 92) 0 © 2023 NOVAVAX. All rights reserved. 38

View entire presentation